On this episode of Neuts World, in the October 31st edition of the National Review, my

guest wrote an op-ed entitled, On Healthcare, the GOP needs a supply side approach with better

messages.

And its peace caught the attention of a member of our team, Joe Desanis, who works with

me on healthcare policy and reform.

I've been working on the issue of healthcare for more than 30 years, and it's one of the

most challenging public policy issues today.

And I wanted to talk about the inflation reduction act's impact on Medicare and drug

development.

So I'm really pleased to welcome my guest, Dr. Thomas Phillips.

He is the Daniel Levin Professor of Public Policy Studies Emeritus at the University of

Chicago, the Harris School of Public Policy, and Direct, the Becker-Freedman Institute's

program on foundational research in healthcare markets and policies within the Health Economics

Initiative.

He has served in several public sector positions, including as a member of the President's Council

of Economic Advisors from 2017 to 2019, and as its chairman from 2019, 2020.

Thomas, welcome, and thank you for joining me on Neuts World.

Thanks for having me.

Let's start if we could before we get into health policy, just with your background, which

is fascinating.

You were born and raised in Sweden and got your undergraduate degree in mathematics at

Upsali University, but then you came to the States and got your MA and PhD in economics

...